Bio-Rad Laboratories, Inc.
Updates & Highlights
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Bio-Rad Laboratories, Inc.?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentBio-Rad Laboratories, Inc. at Wells Fargo Healthcare Conference Transcript
Bio-Rad Laboratories, Inc. at Wells Fargo Healthcare Conference Transcript
GuruFocus · 8 days ago
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
Stock Titan · 10 days ago
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
Stock Titan · 10 days ago
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
Stock Titan · 10 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Current Market Challenges with Strategic Insights
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Current Market Challenges with Strategic Insights
directorstalkinterviews.com · 12 days ago
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity
Stock Titan · 16 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with a -15.14% Potential Downside
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with a -15.14% Potential Downside
DirectorsTalk Interviews · 19 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Upside Amidst Market Challenges
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Upside Amidst Market Challenges
DirectorsTalk Interviews · 26 days ago
EBITDA per share of Bio-Rad Laboratories, Inc. Class A – HAM:BUWA
EBITDA per share of Bio-Rad Laboratories, Inc. Class A – HAM:BUWA
TradingView · 29 days ago
Return on invested capital % of Bio-Rad Laboratories, Inc. Class A – HAM:BUWA
Return on invested capital % of Bio-Rad Laboratories, Inc. Class A – HAM:BUWA
TradingView · 29 days ago
Westport Asset Management Inc. Invests $881,000 in Bio-Rad Laboratories, Inc. $BIO
Westport Asset Management Inc. Invests $881,000 in Bio-Rad Laboratories, Inc. $BIO
MarketBeat · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with Innovative Diagnostics
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with Innovative Diagnostics
DirectorsTalk Interviews · about 1 month ago
First Trust Advisors LP Has $424,000 Position in Bio-Rad Laboratories, Inc. $BIO
First Trust Advisors LP Has $424,000 Position in Bio-Rad Laboratories, Inc. $BIO
MarketBeat · about 1 month ago
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Reduce" from Brokerages
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Reduce" from Brokerages
MarketBeat · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Stock forecasts
Bio-Rad Laboratories, Inc. (BIO) Stock forecasts
Yahoo Finance UK · about 1 month ago
Assenagon Asset Management S.A. Acquires 85,393 Shares of Bio-Rad Laboratories, Inc. $BIO
Assenagon Asset Management S.A. Acquires 85,393 Shares of Bio-Rad Laboratories, Inc. $BIO
MarketBeat · about 1 month ago
US$329 - That's What Analysts Think Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Worth After These Results
US$329 - That's What Analysts Think Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Worth After These Results
富途牛牛 · about 1 month ago
US$329 - That's What Analysts Think Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Worth After These Results
US$329 - That's What Analysts Think Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Worth After These Results
Moomoo · about 1 month ago
Bio-Rad Laboratories, Inc. $BIO Shares Bought by California State Teachers Retirement System
Bio-Rad Laboratories, Inc. $BIO Shares Bought by California State Teachers Retirement System
MarketBeat · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Yahoo Finance · about 1 month ago